DK1696940T3 - Universelt anvendeligt virus-inaktiveret blodplasma fremstillet fra portioner af ikke-kaukasisk plasma - Google Patents

Universelt anvendeligt virus-inaktiveret blodplasma fremstillet fra portioner af ikke-kaukasisk plasma

Info

Publication number
DK1696940T3
DK1696940T3 DK04804944T DK04804944T DK1696940T3 DK 1696940 T3 DK1696940 T3 DK 1696940T3 DK 04804944 T DK04804944 T DK 04804944T DK 04804944 T DK04804944 T DK 04804944T DK 1696940 T3 DK1696940 T3 DK 1696940T3
Authority
DK
Denmark
Prior art keywords
blood
plasma
caucasian
portions
blood plasma
Prior art date
Application number
DK04804944T
Other languages
Danish (da)
English (en)
Inventor
Andrea Heger
Juergen Roemisch
Tor-Einar Svae
Wolfgang Marguerre
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Octapharma Ag filed Critical Octapharma Ag
Application granted granted Critical
Publication of DK1696940T3 publication Critical patent/DK1696940T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01GCOMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G23/00Compounds of titanium
    • C01G23/04Oxides; Hydroxides
    • C01G23/047Titanium dioxide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/16Blood plasma; Blood serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25Silicon; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/29Titanium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82BNANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
    • B82B3/00Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Birds (AREA)
  • Immunology (AREA)
  • Nanotechnology (AREA)
  • Manufacturing & Machinery (AREA)
  • Environmental & Geological Engineering (AREA)
  • General Life Sciences & Earth Sciences (AREA)
  • Geology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • External Artificial Organs (AREA)
DK04804944T 2003-12-19 2004-12-20 Universelt anvendeligt virus-inaktiveret blodplasma fremstillet fra portioner af ikke-kaukasisk plasma DK1696940T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03029359 2003-12-19
PCT/EP2004/053608 WO2005058334A1 (en) 2003-12-19 2004-12-20 A universally applicable virus inactivated blood plasma produced from portions of non-caucasian plasma

Publications (1)

Publication Number Publication Date
DK1696940T3 true DK1696940T3 (da) 2007-07-30

Family

ID=34684548

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04804944T DK1696940T3 (da) 2003-12-19 2004-12-20 Universelt anvendeligt virus-inaktiveret blodplasma fremstillet fra portioner af ikke-kaukasisk plasma

Country Status (23)

Country Link
US (2) US20070071829A1 (pl)
EP (1) EP1696940B1 (pl)
JP (1) JP2007514716A (pl)
KR (1) KR101077976B1 (pl)
CN (1) CN1893960B (pl)
AT (1) ATE357242T1 (pl)
AU (1) AU2004298790B2 (pl)
BR (1) BRPI0417680A (pl)
CA (1) CA2550060A1 (pl)
CY (1) CY1106661T1 (pl)
DE (1) DE602004005501T2 (pl)
DK (1) DK1696940T3 (pl)
ES (1) ES2281848T3 (pl)
IL (1) IL175558A0 (pl)
NO (1) NO20062360L (pl)
PL (1) PL1696940T3 (pl)
PT (1) PT1696940E (pl)
RS (1) RS50508B (pl)
RU (1) RU2362571C2 (pl)
SI (1) SI1696940T1 (pl)
UA (1) UA83528C2 (pl)
WO (1) WO2005058334A1 (pl)
ZA (1) ZA200604941B (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1958618A1 (de) 2007-02-15 2008-08-20 Octapharma AG Verfahren zur Gefriertrocknung mit optimierter Rekonstitution von Biopolymeren
FR2963737B1 (fr) * 2010-08-16 2013-04-05 Etat Francais Ministere De La Defense Service De Sante Des Armees Procede de lyophilisation de plasma sanguin
EP3093035A1 (en) 2015-05-13 2016-11-16 Sanofi-Aventis Deutschland GmbH Injection device for delivery of a liquid medicament
CN107496453A (zh) * 2017-08-13 2017-12-22 发贵科技(贵州)有限公司 一种有病毒灭活功能的血浆抗凝剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4664913A (en) * 1982-05-24 1987-05-12 Xoma Corporation Method for treating plasma for transfusion
US4764369A (en) * 1983-07-14 1988-08-16 New York Blood Center Inc. Undenatured virus-free biologically active protein derivatives
US5217627A (en) * 1990-11-06 1993-06-08 Pall Corporation System and method for processing biological fluid
AU667530B2 (en) * 1992-05-28 1996-03-28 New York Blood Center, Inc., The Removal of antibodies from blood-derived compositions while retaining coagulation factors
EP0896824A1 (en) * 1997-08-05 1999-02-17 Octapharma Ag A universally applicable blood plasma
CN1207004C (zh) * 2001-04-18 2005-06-22 马建川 通用型冻干血浆及其制备方法
US20030133829A1 (en) * 2001-12-21 2003-07-17 Baxter Healthcare Corporation Process for inactivating pathogens in a biological material

Also Published As

Publication number Publication date
AU2004298790B2 (en) 2010-04-08
WO2005058334A1 (en) 2005-06-30
ZA200604941B (en) 2007-11-28
DE602004005501T2 (de) 2007-11-29
US20070071829A1 (en) 2007-03-29
EP1696940B1 (en) 2007-03-21
AU2004298790A1 (en) 2005-06-30
CN1893960B (zh) 2012-10-31
UA83528C2 (uk) 2008-07-25
PT1696940E (pt) 2007-05-31
CY1106661T1 (el) 2012-05-23
RS50508B (sr) 2010-03-02
EP1696940A1 (en) 2006-09-06
RU2006126055A (ru) 2008-01-27
ATE357242T1 (de) 2007-04-15
CN1893960A (zh) 2007-01-10
DE602004005501D1 (de) 2007-05-03
BRPI0417680A (pt) 2007-03-20
NO20062360L (no) 2006-05-23
JP2007514716A (ja) 2007-06-07
US20110104298A1 (en) 2011-05-05
IL175558A0 (en) 2006-09-05
ES2281848T3 (es) 2007-10-01
KR101077976B1 (ko) 2011-10-28
RU2362571C2 (ru) 2009-07-27
CA2550060A1 (en) 2005-06-30
PL1696940T3 (pl) 2007-08-31
SI1696940T1 (sl) 2007-08-31
KR20060126662A (ko) 2006-12-08

Similar Documents

Publication Publication Date Title
CY1122076T1 (el) Φυτικα εκχυλισματα που περιεχουν κανναβινοειδες σαν νευρο-προστατευτικοι παραγοντες
CY1113963T1 (el) Φαρμακευτικες συνθεσεις οι οποιες περιλαμβανουν ανταγωνιστες ακτιβινης-actriia και χρηση αυτων στην προληψη η' θεραπευτικη αγωγη πολλαπλου μυελωματος
CR20110172A (es) Composiciones antimicrobianas
DK1556021T3 (da) Farmaceutiske sammensætninger omfattende flavonoider og menthol samt fremgangsmåder til behandling med brug af nævnte sammensætninger
BRPI0418251A (pt) fosfonatos, monofosfonamidatos, bisfosfonamidatos para o tratamento de doenças virais
LTC1608344I2 (lt) Per burną vartojamos kladribino kompozicijos
CR7901A (es) Pirazolilcarboxanilidas para la lucha contra los microorganismos indeseados
EA200802213A1 (ru) Способы лечения заболеваний крови
CU20080010A7 (es) Inhibidores macrocíclicos de la replicación del virus de la hepatitis c
DK1753440T3 (da) Oral administrationsform indeholdende probiotiske bakterier
BR0307833A (pt) Sìntese controlada de ziprasidona e suas composições
IL178727A0 (en) Tetrahydropyridothiophene derivatives and pharmaceutical compositions containing the same
DE602004031134D1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
UA95715C2 (ru) Фосфадиазиновые производные, фармацевтическая композиция и их применение
UY29236A1 (es) 2-alcoxi-3,4,5-trihidroxi-alquilamidas. su preparación, composiciones que las contienen y su utilización.
CR8135A (es) Triazolopirimidinas
ATE457977T1 (de) Biguanidderivate
UY29999A1 (es) "n-pirazinil-fenilsulfonamidas, procedimientos y compuestos intemedios utilizados en su preparacion, composiciones farmaceuticas que las contienen y aplicaciones"
IL175558A0 (en) A universally applicable virus inactivated blood plasma produced from portions of non-caucasian plasma
ATE397861T1 (de) Synergistische zusammensetzungen
UY30023A1 (es) Nueva asociacion de un inhibidor de la corriente sinusal i, y de un inhibidor calcico y las composiciones farmaceuticas que la contienen
RS51534B (en) NEW COMPOUND OF SINUSOID IF CURRENT INHIBITORS AND CALCIUM INHIBITOR AND PHARMACEUTICAL MIXTURE CONTAINED BY IT
DK1633373T3 (da) Farmaceutisk sammensætning indeholdende glucan hidrørende fra mikroalger
AR060155A1 (es) Combinaciones de principios activos con propiedades insecticidas y acaricidas
CR8073A (es) Iodopyrazolyl carboxanilidas